Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Sapio Sciences’ Release 24.12 enhances lab informatics with improved GMP workflows and molecular biology features, driving efficiency and scientific discovery.

Amylyx axes ALS drug from market after Phase III failure – Pharmaceutical Technology

Share this article Amylyx’ ALS candidate Relyvrio has been taken off the market following a Phase III trial that missed its endpoints. Credit: MacroEcon via

April 5, 2024

Case Western Reserve University receives grant to investigate AML treatment for veterans

With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University are investigating a new approach

October 15, 2024

White House Opens Gun Violence Prevention Office

The Biden administration said it is opening an Office of Gun Violence Prevention to focus more attention and resources on the issue. “Guns are the

September 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.